Struggling to Conceive? Your Genes May Hold the Answer.

MTHFR is your cell’s primary methylation enzyme. Methylation is one of the most important chemical reactions in your body. It turns nutrients into usable energy, repairs DNA, regulates gene expression, and controls inflammation. In pregnancy, methylation becomes critical. Embryos require perfect methylation to close the neural tube, develop organs, and establish healthy epigenetic patterns that affect the child for life.

The MTHFR C677T variant, carried by roughly 40% of people of European ancestry, reduces the enzyme’s efficiency by 40 to 70%. Heterozygous carriers have reduced function; homozygous carriers have significantly impaired function. If you carry this variant, your cells cannot convert regular B vitamins into their active, methylated forms at a rate that supports healthy embryo development. You’re not getting enough methylation support even if your diet is perfect and your prenatal vitamin is premium.

What this means for you: conception takes longer, miscarriage risk is higher, and when pregnancy does occur, the nutritional demands are even greater. Your homocysteine levels may creep up, which itself damages sperm DNA and reduces egg quality. You may experience recurrent miscarriage even with chromosomally normal embryos. Many women with MTHFR variants don’t realize that their three miscarriages and two failed IVF cycles could have been prevented by simple methylation support.

FSHR is the follicle-stimulating hormone receptor. It sits on the surface of your ovarian follicles and listens for FSH signals. When FSH binds to FSHR, it tells your follicles to grow, mature, and produce estrogen. Without proper FSHR signaling, your ovaries don’t respond to FSH, even when FSH levels are high.

The FSHR N680S variant, carried by roughly 10 to 15% of women, creates a receptor that is less sensitive to FSH. If you carry the S/S genotype, your ovaries require significantly more FSH stimulation to produce the same egg maturation as women without the variant. This shows up clinically as poor ovarian response during natural cycles or during IVF stimulation. You may ovulate late in your cycle, produce fewer follicles during IVF, or require higher doses of injectable FSH to achieve the same response as other women.

What this means for you: if you’re doing IVF and your clinic is surprised by your poor response to standard dosing, FSHR may be the reason. Your ovaries aren’t broken. They’re just less sensitive. You need a different stimulation protocol. Many women undergo repeated failed IVF cycles before anyone recognizes the FSHR variant and adjusts the protocol accordingly.

ESR1 codes for the estrogen receptor, a protein that sits in your endometrial cells and responds to estrogen. Estrogen receptors control the timing of endometrial maturation, the secretion of implantation-promoting proteins, and the window of implantation receptivity. Variants in ESR1 change how sensitive your endometrium is to estrogen signaling.

ESR1 variants (PvuII and XbaI polymorphisms), present in roughly 40% of women, alter the efficiency of estrogen receptor binding and function. If you carry certain ESR1 variants, your endometrium may not mature properly in response to estrogen, even when estrogen levels are adequate. This creates a mismatch between hormone levels and tissue readiness. Your estrogen may be perfect, but your endometrium isn’t receiving or responding to the signal correctly. Implantation window timing may be off by one to two days. Embryo adhesion and invasion may be suboptimal.

What this means for you: you may experience repeated implantation failure with genetically normal embryos. Your endometrial thickness may look fine on ultrasound, but at the cellular level, implantation machinery isn’t activated properly. You may have an endometrial receptivity window that opens and closes on a different schedule than a standard protocol assumes. This is invisible on standard fertility testing.

CFTR codes for a chloride channel protein essential for normal development of the vas deferens, the tube that carries sperm from the testicles to the urethra. Carriers of CFTR mutations can have congenital bilateral absence of the vas deferens (CBAVD), meaning the sperm-transport pathway never developed. Sperm production itself is normal. The sperm just have nowhere to go.

CFTR carrier variants, present in roughly 1 in 25 people of European ancestry, can cause obstructive azoospermia. A man can have completely normal testicular function, normal hormone levels, and produce healthy sperm, but if his vas deferens is absent or blocked due to CFTR variants, his ejaculate will contain zero sperm. Semen analysis shows azoospermia. A urologist may suspect a primary testicular problem when the real problem is developmental: the transportation system was never built.

What this means for him: conventional fertility workup attributes the problem to low sperm production. Hormone replacement or lifestyle changes won’t help because the issue isn’t production; it’s anatomy. However, sperm can be retrieved directly from the testicles via surgical extraction (TESE, TESA, PESA) and used for IVF with ICSI. Knowing CFTR status upfront prevents months of futile treatment.

DAZL (deleted in azoospermia-like) is one of the azoospermia factor genes on the Y chromosome. It codes for a protein critical for the earliest stages of sperm development. Without functional DAZL, the testis cannot begin spermatogenesis. Deletions in the AZF region (azoospermia factor region) on the Y chromosome eliminate genes like DAZL and cause azoospermia or severe oligospermia.

DAZL deletions (AZFa, AZFb, AZFc deletions), present in roughly 1 in 2,000 to 3,000 men with infertility, cause complete or near-complete loss of sperm production. A man with a DAZL deletion can have normal hormones, normal testicular volume on exam, and completely absent or extremely low sperm count because the genetic instructions for making sperm are simply not there. This is not a hormone problem. It’s a genetic blueprint problem.

What this means for him: azoospermia due to DAZL deletion is not reversible with lifestyle, supplements, or hormone therapy. His testis cannot produce sperm because the genes that control sperm development are missing. However, in some cases (AZFb, AZFc), trace amounts of sperm may still be present and can be surgically retrieved for IVF with ICSI. Genetic counseling is essential because Y deletions can be inherited by sons.

The androgen receptor (AR) is a protein found in testicular cells that receives testosterone signals and activates genes necessary for spermatogenesis. The AR gene contains a variable-length CAG repeat. Longer repeats create a less sensitive androgen receptor; shorter repeats create a more sensitive one. This variation is common in the population.

AR CAG repeat length varies widely, and longer repeats (typically 25 or more) are associated with reduced androgen receptor sensitivity. If you carry longer CAG repeats, your testis responds less efficiently to testosterone, resulting in slower spermatogenesis, lower sperm count, and reduced sperm motility, even when testosterone levels are in the normal range. Your testosterone is fine. Your testis just doesn’t hear the signal as well.

What this means for you: you may have borderline or low-normal sperm count with completely normal testosterone levels. Testosterone replacement won’t help and may actually make things worse by suppressing endogenous testosterone and the small sperm production you do have. Interventions need to target the downstream effects of androgen signaling rather than hormone levels.